Viewing Study NCT01921751


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-21 @ 12:21 PM
Study NCT ID: NCT01921751
Status: TERMINATED
Last Update Posted: 2018-07-13
First Post: 2013-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Sponsor: Radiation Therapy Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Adenocarcinoma View
None Stage III Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SMAD4 View
None IMRT View
None gemcitabine View
None high-dose radiotherapy View